Rare Disease & Gene Therapy Digest • October 5, 2026 Rare Disease & Gene Therapy Digest October 5, 2026 Shionogi agreed to buy Texas-based IntraBio for $2 billion… Pro Hub Membership Required You must be a Pro Hub member to access this content. Join Now Already a member? Log in here